Description

C-[3-(5'-(Trifluoromethyl)Pyridin-2'-Yl)-[1,2,4] Oxadiazol-5-Yl]--Methylammonium Trifluoroacetate is a high-purity, advanced pharmaceutical intermediate characterized by its unique heterocyclic structure incorporating oxadiazole and pyridine motifs. This compound is critical for research and development in medicinal chemistry, particularly for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by pharmaceutical R&D laboratories, agrochemical innovators, and specialty chemical manufacturers engaged in developing new therapeutics and crop protection agents.

Application

• Pharmaceutical Intermediate: A crucial building block for the synthesis of novel drug candidates, particularly in oncology, neurology, and anti-infective therapeutic areas.
• Agrochemical Research: Serves as a key precursor in the development of new-generation pesticides and herbicides, leveraging its heterocyclic scaffold.
• Chemical Biology Probe: Used in biochemical assays and as a molecular tool for studying enzyme inhibition and protein-ligand interactions.
• Material Science Research: Investigated for its potential application in the synthesis of specialty polymers and advanced organic electronic materials.
• Contract Research & Development (CRO/CMO): Supplied to organizations providing custom synthesis and process development services for the life sciences industry.

Basic Information

Item	Detail
Product Name	C-[3-(5'-(Trifluoromethyl)Pyridin-2'-Yl)-[1,2,4] Oxadiazol-5-Yl]--Methylammonium Trifluoroacetate
CAS No.	1208081-75-7
Molecular Formula	C12H9F6N4O3
Molecular Weight	371.22 g/mol
Synonyms	5-(Aminomethyl)-3-[5-(trifluoromethyl)-2-pyridinyl]-1,2,4-oxadiazole Trifluoroacetate; 3-(5-(Trifluoromethyl)pyridin-2-yl)-1,2,4-oxadiazol-5-ylmethanaminium trifluoroacetate; (3-(5-(Trifluoromethyl)pyridin-2-yl)-1,2,4-oxadiazol-5-yl)methanaminium 2,2,2-trifluoroacetate; TFA Salt of C-[3-(5'-(Trifluoromethyl)Pyridin-2'-Yl)-[1,2,4] Oxadiazol-5-Yl]--Methylamine; CAS 1208081-75-7
EINECS	Contact for details

Quality Control

Our C-[3-(5'-(Trifluoromethyl)Pyridin-2'-Yl)-[1,2,4] Oxadiazol-5-Yl]--Methylammonium Trifluoroacetate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided with every shipment. We adhere to cGMP principles where applicable to support our clients' regulatory requirements for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled under dry conditions to prevent degradation. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.